Abstract
The diagnosis of incidental small renal masses (SRM) has increased during the past two decades secondary to the increased use of various abdominal imaging modalities. In the past decade, there has been a shift from radical nephrectomy to nephron-sparing surgery techniques where partial nephrectomy has become the standard of care. Thermal ablation (TA) modalities such as freezing or heating delivered percutaneously for the treatment of small renal masses (SRM) are now offered in most institutions as a treatment option. Clinical guidelines have indicated that TA is appropriate for select patients that are medically high risk or elderly. In our institution and in select centres, TA is discussed and often offered for all patients with SRM as equivalent treatment without respect to age or co-morbidities. As provider experience improves and long-term outcome studies become available, TA is becoming increasingly accepted as a potential new standard of care for solid SRM. This review will highlight the role of image-guided radiofrequency ablation (RFA) techniques and their application focusing on the different imaging modalities for RFA application which, most commonly, include percutaneous (magnetic resonance imaging (MRI) and computerized tomography (CT)). Our aim is to summarize those studies along with long-term follow-up.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- CA:
-
Cryoablation
- EMN:
-
Electromagnetic navigation
- MWA:
-
Microwave ablation
- NSS:
-
Nephron-sparing surgery
- PN:
-
Partial nephrectomy
- RCC:
-
Renal cell carcinoma
- RFA:
-
Radiofrequency ablation
- RN:
-
Radical nephrectomy
- SRM:
-
Small renal masses
- TA:
-
Thermal ablation
References
Glamore M, Leveillee R. CT-guided renal ablation. In: Liao JC, Su L, editors. Advances in image-guided urologic surgery. New York: Springer; 2015. p. 175–84. doi:10.1007/978-1-4939-1450-0.
Ordon M, Findeiss L, Landman J. MR-guided renal ablation. In: Liao JC, Su L, editors. Advances in image-guided urologic surgery. New York: Springer; 2015. p. 185–99. doi:10.1007/978-1-4939-1450-0.
Campbell SC, Novick AC, Belldegrun A, et al. Guideline for management of the clinical T1 renal mass. J Urol. 2009;182(4):1271–9.
Sterrett SP, Nakada SY, Wingo MS, Williams SK, Leveillee RJ. Renal thermal ablative therapy. Urol Clin North Am. 2008;35(3):397–414.
Castro A Jr, Jenkins LC, Salas N, Lorber G, Leveillee RJ. Ablative therapies for small renal tumours. Nat Rev Urol. 2013;10(5):284–91.
Castle SM, Gorbatiy V, Avallone MA, Eldefrawy A, Caulton DE, Leveillee RJ. Cost comparison of nephron-sparing treatments for cT1a renal masses. Urol Oncol. 2013;31(7):1327–32.
Gorin MA, Gahan J, Antebi E, Carey RI, Bird VG. Laparoscopic-guided radiofrequency ablation is safe for the treatment of enhancing renal masses among patients prescribed antithrombotic agents. Clin Appl Thromb Hemost. 2012;18(1):35–9.
Zagoria RJ, Pettus JA, Rogers M, Werle DM, Childs D, Leyendecker JR. Long-term outcomes after percutaneous radiofrequency ablation for renal cell carcinoma. Urology. 2011;77(6):1393–7.
Olweny EO, Park SK, Tan YK, Best SL, Trimmer C, Cadeddu JA. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up. Eur Urol. 2012;61(6):1156–61.
Psutka SP, Feldman AS, McDougall WS, et al. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma. Eur Urol. 2013;63(3):486–92.
Salas N, Castle SM, Leveillee RJ. Radiofrequency ablation for treatment of renal tumours: technological principles and outcomes. Expert Rev Med Devices. 2011;8(6):695–707.
Wingo MS, Leveillee RJ. Central and deep renal tumours can be effectively ablated: radiofrequency ablation outcomes with fibre optic peripheral temperature monitoring. J Endourol. 2008;22(6):1261–7.
Lorber G, Glamore M, Doshi M, Jorda M, Morillo-Burgos G, Leveillee RJ. Long-term oncologic outcomes following radiofrequency ablation with real-time temperature monitoring for T1a renal cell cancer. Urol Oncol. 2014;32(7):1017–23.
Ferakis N, Bouropoulos C, Granitsas T, Mylona S, Poulias I. Long-term results after computed-tomography-guided percutaneous radiofrequency ablation for small renal tumours. J Endourol. 2010;24(12):1909–13.
Carey RI, Leveillee RJ. First prize: direct real-time temperature monitoring for laparoscopic and CT-guided radiofrequency ablation of renal tumours between 3 and 5 cm. J Endourol. 2007;21(8):807–13.
Lay AH, Faddegon S, Olweny EO, et al. Oncologic efficacy of radio frequency ablation for small renal masses: clear cell vs papillary subtype. J Urol. 2015;194(3):653–7.
Uppot RN, Silverman SG, Zagoria RJ, Tuncali K, Childs DD, Gervais DA. Imaging-guided percutaneous ablation of renal cell carcinoma: a primer of how we do it. AJR Am J Roentgenol. 2009;192(6):1558–70.
Fallone BG, Moran PR, Podgorsak EB. Noninvasive thermometry with a clinical x-ray CT scanner. Med Phys. 1982;9:715–21.
Cheng EY, Naranje SM, Ritenour ER. Radiation dosimetry of intraoperative cone-beam compared with conventional CT for radiofrequency ablation of osteoid osteoma. J Bone Joint Surg Am. 2014;96(9):735–42.
Leveillee RJ, Castle SM, Salas N, Doshi M, Gorbatiy V, O’Neill W. Improved targeting of radio-frequency ablation probes and thermal sensors: a preliminary investigation of flat-panel CT guided ablation of renal tumours in the cardiac catheterization lab. J Endourol. 2011;25(7):1119–23.
Krucker J, Xu S, Venkatesan A, et al. Clinical utility of real-time fusion guidance for biopsy and ablation. J Vasc Interv Radiol. 2011;22(4):515–24.
Leveillee RJ, Ramanathan R. Optimization of image-guided targeting in renal focal therapy. J Endourol. 2010;24(5):729–44.
Venkatesan AM, Kadoury S, Abi-Jaoudeh N, et al. Real-time FDG PET guidance during biopsies and radiofrequency ablation using multimodality fusion with electromagnetic navigation. Radiology. 2011;260(3):848–56.
Hung AJ, Ma Y, Zehnder P, Nakamoto M, Gill IS, Ukimura O. Percutaneous radiofrequency ablation of virtual tumours in canine kidney using global positioning system-like technology. BJU Int. 2012;109(9):1398–403.
Venkatesan AM, Wood BJ, Gervais DA. Percutaneous ablation in the kidney. Radiology. 2011;261(2):375–91.
Boss A, Clasen S, Kuczyk M, Schick F, Pereira PL. Image-guided radiofrequency ablation of renal cell carcinoma. Eur Radiol. 2007;17(3):725–33.
Hong J, Dohi T, Hasizume M, Konishi K, Hata N. Ultrasound guided motion adaptive instrument for percutaneous needle insertion therapy. In: 6th International conference on biomedical engineering and rehabilitation engineering. China: Guilin; 2002. p. 225–7.
Solomon SB, Patriciu A, Bohlman ME, et al. Robotically driven interventions: a method of using CT fluoroscopy without radiation exposure to the physician. Radiology. 2002;225:277–82.
Jacobi V, Thalihammer A, Kirchner J. Value of a laser guidance system for CT interventions: a phantom study. Eur Radiol. 1999;9:137–40.
Lehman DS, Hruby GW, Phillips CK, McKiernan JM, Benson MC, Landman J. First prize (tie): laparoscopic renal cryoablation: efficacy and complications for larger renal masses. J Endourol. 2008;22(6):1123–7.
Farrell MA, Charboneau JW, Callstrom MR, Reading CC, Engen DE, Blute ML. Paranephric water instillation: a technique to prevent bowel injury during percutaneous renal radiofrequency ablation. AJR Am J Roentgenol. 2003;181(5):1315–7.
Haas NB. Surveillance for renal cell cancer recurrence: which patients should undergo imaging, how often, and when? J Clin Oncol. 2015;33(35):4131–3.
Ma Y, Bedir S, Cadeddu JA, Gahan JC. Long-term outcomes in healthy adults after radiofrequency ablation of T1a renal tumours. BJU Int. 2014;113(1):51–5.
Kim SD, Yoon SG, Sung GT. Radiofrequency ablation of renal tumours: four-year follow-up results in 47 patients. Korean J Radiol. 2012;13(5):625–33.
Tracy CR, Raman JD, Donnally C, Trimmer CK, Cadeddu JA. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years. Cancer. 2010;116(13):3135–42.
Balageas P, Cornelis F, Le Bras Y, et al. Ten-year experience of percutaneous image-guided radiofrequency ablation of malignant renal tumours in high-risk patients. Eur Radiol. 2013;23(7):1925–32.
Ramirez D, Ma YB, Bedir S, Antonelli JA, Cadeddu JA, Gahan JC. Laparoscopic radiofrequency ablation of small renal tumours: long-term oncologic outcomes. J Endourol. 2014;28(3):330–4.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Kelly, E.F., Leveillee, R.J. (2018). Image-Guided Radiofrequency Ablation for Small Renal Masses. In: Ahmed, K., Raison, N., Challacombe, B., Mottrie, A., Dasgupta, P. (eds) The Management of Small Renal Masses. Springer, Cham. https://doi.org/10.1007/978-3-319-65657-1_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-65657-1_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-65656-4
Online ISBN: 978-3-319-65657-1
eBook Packages: MedicineMedicine (R0)